Angiotensin receptor blockers in chronic renal disease: The promise of a bright clinical future

Journal of the American Society of Nephrology

Volumn 10, Issue 4 SUPPL., 1999, Pages

  Mackenzie, Harald S ^a,b   Ziai, Farzad ^a   Omer, Saeed A ^a   Nadim, Mitra K ^a   Taal, Maarten W ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 ETHYL 5,7 DIMETHYL 3 [4 [2 (2H TETRAZOL 5 YL)PHENYL]BENZYL]IMIDAZO[4,5 B]PYRIDINE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR; CANDESARTAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; IRBESARTAN; LOSARTAN; VALSARTAN;

BLOOD PRESSURE REGULATION; CELL PROTECTION; CHRONIC KIDNEY DISEASE; CLINICAL PRACTICE; COMBINATION CHEMOTHERAPY; DRUG EFFICACY; DRUG MECHANISM; DRUG RECEPTOR BINDING; GLOMERULOSCLEROSIS; HUMAN; HYPERTENSION; KIDNEY INJURY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEINURIA; RAT; RECEPTOR BLOCKING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; TREATMENT OUTCOME;

EID: 0032953218     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Mackenzie HS, Brenner BM: Current strategies for retarding the progression of renal disease. Am J Kidney Dis 31: 161-170, 1998
2. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD, for the Collaborative Study Group: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 329: 1456-1462, 1993
3. Maschio G, Alberti D, Janin G, Locatelli F, Mann J, Motolese M, Ponticelli C, Ritz E, Zucchelli P, and the Angiotensin-Converting Enzyme Inhibition in Progressive Renal Insufficiency Study Group: Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med 334: 939-945, 1996
4. Anderson S, Meyer TW, Rennke HG, Brenner BM: Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest 76: 612-619, 1985
5. Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM: Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 77: 1925-1930, 1986
6. Iimura O, Shimamoto K: Role of kallikrein-kinin system in the hypotensive mechanisms of converting enzyme inhibitors in essential hypertension. J Cardiovasc Pharmacol 13: S63-S66, 1989
7. Goldberg MR, Bradstreet TE, McWilliams EJ, Tanaka WK, Lipert S, Bjornsson TD, Waldman SA, Osborne B, Pivadori L, Lewis G, Blum R, Herman T, Abraham PA, Halstenson CN, Lo M, Lu H, Spector R: Biochemical effects of losartan, a nonpeptide angiotensin II receptor antagonist, on the renin-angiotensin-aldosterone system in hypertensive patients. Hypertension 25: 37-46, 1995
8. 1 receptor: Gain-of-function study using gene transfer. Proc Natl Acad Sci USA 92: 10663-10667, 1996
9. Lafayette RA, Mayer G, Park SK, Meyer TW: Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass. J Clin Invest 90: 766-771, 1992
10. Mackenzie HS, Troy JL, Rennke HG, Brenner BM: TCV 116 prevents progressive renal injury in rats with extensive renal mass ablation. J Hypertens 12[Suppl 9]: S11-S16, 1994
11. Kakinuma Y, Kawamura T, Bills T, Yoshioka T, Ichikawa I, Fogo A: Blood pressure-independent effect of angiotensin inhibition on vascular lesions of chronic renal failure. Kidney Int 42: 46-55, 1992
12. Pollock DM, Divish BJ, Polakowski JS, Opgenorth TJ: Angiotensin II receptor blockade improves renal function in rats with reduced renal mass. J Pharmacol Exp Ther 267: 657-663, 1993
13. Brooks DP, Contino LC, Short BG, Gowan C, Trizna W, Edwards RM: SB 203220: A novel angiotensin II receptor antagonist and renoprotective agent. J Pharmacol Exp Ther 274: 1222-1227, 1995
14. Okada H, Suzuki H, Kanno Y, Ikenaga H, Saruta T: Renal responses to angiotensin receptor antagonist and angiotensin-converting enzyme inhibitor in partially nephrectomized spontaneously hypertensive rats. J Cardiovasc Pharmacol 26: 564-569, 1995
15. Wu LL, Cox A, Roe CJ, Dziadek M, Cooper ME, Gilbert RE: Transforming growth factor beta 1 and renal injury following subtotal nephrectomy in the rat: Role of the renin-angiotensin system. Kidney Int 51: 1553-1567, 1997
16. Ots M, Mackenzie HS, Troy JL, Brenner BM: Effects of combination therapy with enalapril and losartan on the rate of progression of renal injury in rats with 5/6 renal mass ablation. J Am Soc Nephrol 9: 224-230, 1998
17. Noda M, Fuduko R, Matsuo T, Ohta M, Nagano H, Imura Y, Nishikawa K, Shibouta Y: Effects of candesartan cilexetil (TCV-116) and enalapril in 5/6 nephrectomized rats. Kidney Int 52[Suppl 63]: S136-S139, 1997
18. Ziai F, Ots M, Provoost AP, Troy JL, Rennke HG, Brenner BM, Mackenzie HS: The angiotensin receptor antagonist, irbesartan, reduces renal injury in experimental chronic renal failure. Kidney Int 50[Suppl 57]: S132-S136, 1996
19. Imamura A, Mackenzie HS, Lacy ER, Hutchison FN, Fitzgibbon WR, Ploth DW: Effects of chronic treatment with angiotensin converting enzyme inhibitor or an angiotensin receptor antagonist in two-kidney, one-clip hypertensive rats. Kidney Int 47: 1394-1402, 1995
20. Anderson A, Tolbert E, Esparza A, Dworkin L: Effects of an ACE inhibitor (ACEI) vs. an All antagonist (AA) on hemodynamics, growth, and injury in spontaneously hypertensive rats (SHR) [Abstract]. J Am Soc Nephrol 7: 1849, 1996
21. Remuzzi A, Malanchini B, Battaglia C, Bertani T, Remuzzi G: Comparison of the effects of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade on the evolution of spontaneous glomerular injury in male MWF/Ztm rats. Exp Nephrol 4: 19-25, 1996
22. Shihab FS, Bennett WM, Tanner AM, Andoh TF: Angiotensin II blockade decreases TGF-betal and matrix proteins in cyclosporine nephropathy. Kidney Int 52: 660-673, 1997
23. Inada Y, Wada T, Ojima M, Sanada T, Shibouta Y, Kanagawa K, Ishimura Y, Fujisawa Y, Nishikawa K: Protective effects of candesartan cilexetil (TCV-116) against stroke, kidney dysfunction and cardiac hypertrophy in stroke-prone spontaneously hypertensive rats. Clin Exp Hypertens 19: 1079-1099, 1997
24. Otsuka F, Yamauchi T, Kataoka H, Mimura Y, Ogura T, Makino H: Effects of chronic inhibition of ACE and AT1 receptors on glomerular injury in Dahl salt-sensitive rats. Am J Physiol 274: R1797-R1806, 1998
25. Remuzzi A, Perico N, Amuchastegui CS, Malanchini B, Mazerska M, Battaglia C, Bertani T, Remuzzi G: Short-and long-term effect of angiotensin II receptor blockade in rats with experimental diabetes. J Am Soc Nephrol 4: 40-49, 1993
26. Remuzzi A, Fassi A, Sangalli F, Malanchini B, Mohamed EI, Bertani T, Remuzzi G: Prevention of renal injury in diabetic MWF rats by angiotensin II antagonism. Exp Nephrol 6: 28-38, 1998
27. Kato S, Luyckx VA, Lee K-W, Troy JL, Brenner BM, Mackenzie HS: Inhibition of renin-angiotensin system suppresses expression of cytokines and growth factors in streptozotocin-treated diabetic rats [Abstract]. J Am Soc Nephrol 8: 640A, 1997
28. Zoja C, Donadelli R, Corna D, Testa D, Facchinetti D, Maffi R, Luzzana E, Colosio V, Bertani T, Remuzzi G: The renoprotective properties of angiotensin-converting enzyme inhibitors in a chronic model of membranous nephropathy are solely due to the inhibition of angiotensin II: Evidence based on comparative studies with a receptor antagonist. Am J Kidney Dis 29: 254-264, 1997
29. Zoja C, Abbate M, Corna D, Capitanio M, Donadelli R, Bruzzi I, Oldroyd S, Benigni A, Remuzzi G: Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritis. Am J Kidney Dis 31: 453-463, 1998
30. Mackenzie HS, Ziai F, Nagano H, Azuma H, Troy JL, Rennnke HG, Tilney NL, Brenner BM: Candesartan cilexetil reduces chronic renal allograft injury in Fisher→Lewis rats. J Hypertens 15[Suppl 4]: S21-S25, 1997
31. Ziai F, Nagano H, Rennke HG, Tilney NL, Brenner BM, Mackenzie HS: Renal protective effects of losartan in F344→Lew rats [Abstract]. J Am Soc Nephrol 8: 670A, 1997
32. Benediktsson H, Chea R, Davidoff A, Paul LC: Antihypertensive drug treatment in chronic renal allograft rejection in the rat: Effect on structure and function. Transplantation 62: 1634-1642, 1996
33. Amuchastegui SC, Azollini N, Mister M, Pezzotta A, Perico N, Remuzzi G: Chronic allograft nephropathy in the rat is improved by angiotensin II receptor blockade but not by calcium channel antagonism. J Am Soc Nephrol 9: 1948-1955, 1998
34. Kingma I, Chea R, Davidoff A, Benediktsson H, Paul LC: Glomerular capillary pressures in long-surviving rat renal allografts. Transplantation 56: 53-60, 1993
35. Junaid A, Kren SM, Rosenberg ME, Nath KA, Hosteller TH: Physiological and structural responses to chronic experimentel renal allograft injury. Am J Physiol 267: F1102-F1106, 1994
36. Mackenzie HS, Azuma H, Troy JL, Rennke HG, Tilney NL, Brenner BM: Augmenting kidney mass at transplantation abrogates chronic renal allograft injury in rats. Proc Assoc Am Physicians 108: 127-133, 1996
37. Burdmann EA, Andoh TF, Nast CC, Evan A, Connors BA, Coffman TM, Lindley J, Bennett WM: Prevention of experimental cyclosporin-induced interstitial fibrosis by losartan and enalapril. Am J Physiol 269: F491-F499, 1995
38. Carretero OA, Polomski C, Scicli AG: Role of kinins and nitric oxide in the renal protective effects of ACEI in the subtotal nephrectomy model [Abstracl]. Hypertension 22: 415, 1993
39. Nabokov A, Amann K, Gassmann P, Schwarz U, Orth SR, Ritz E: The renoprotective effect of angiotensin-converting enzyme inhibitors in experimenlal chronic renal failure is not dependent on enhanced kinin activity. Nephrol Dial Transplant 13: 173-176, 1998
40. Mackenzie HS, Ots M, Ziai F, Lee K-W, Kato S, Brenner BM: Angiotensin receptor antagonists in experimental models of chronic renal failure. Kidney Int 52[Suppl 63]: S140-S143, 1997
41. 1RA [Abstract]. J Am Soc Nephrol 9:622A, 1998
42. Gansevoort RT, de Zeeuw D, Shahinfar S, Redfield A, de Jong PE: Effects of the angiotensin antagonist losartan in hypertensive patients with renal disease. J Hypertens Suppl 12: S37-S42, 1994
43. Pitt B, Segal R, Martinez FA, Meurers G, Cowley AJ, Thomas I, Deedwania PC, Ney DE, Snavely DB, Chang PI: Randomized trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet 349: 747-752, 1997